NOMURA FINANCIAL PRODUCTS EUROPE GMBH
Location
MILANO
Founded
2018-12-12
Website
Risk Signals
877 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Miscellaneous business Credit Institutions), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about NOMURA FINANCIAL PRODUCTS EUROPE GMBH
Live alerts from global media, monitored by Business Radar
2025-04-21 (investing.com)
Nomura lowers HDFC Life rating to neutral, maintains price target inr735 by .com
Nomura lowers HDFC Life rating to Neutral, maintains price target inr735
Read more
2025-04-01 (fitchratings.com)
Nomura Holdings, Inc.
The ratings on Nomura Holdings, Inc. reflect Fitch Ratings' view that the group is very likely to receive government support due to its systemic importance...
Read more
2025-02-25 (marketscreener.com)
Nomura Downgrades Bilibili to Neutral From Buy, Adjusts Price Target to $25 From $20 -February 25, 2025 at 06:53 am EST |
Bilibili has an average rating of overweight and mean price target of $25.22, according to analysts polled by FactSet. ...
Read more
2025-02-19 (businessupturn.com)
Nomura downgrades ABB to 'Reduce', cuts target price to ₹4,970 |
Nomura has downgraded ABB India to Reduce, slashing its target price to ₹4,970 per share. The decision comes after the company's order inflows missed estimates by 24%.
Read more
2025-02-17 (businessupturn.com)
Brokerages cut target price for Samvardhana Motherson shares after Q3 results |
Samvardhana Motherson reported a weaker-than-expected Q3 performance, prompting both Nomura and JPMorgan to cut their target prices for the stock. Nomura downgraded its target to ₹155 from ₹209, while JPMorgan lowered its target to ₹160 from ₹190, citing near-term uncertainties in the global auto market. Nomura highlighted that while the company's acquisitions and ramp-up in […]
Read more
2025-02-10 (businessupturn.com)
What to buy and sell today (February 10): M&M, SBI, Fortis among top picks, LIC & Ola Electric in focus |
As markets navigate earnings season and macroeconomic trends, brokerage firms have issued fresh recommendations on which stocks to buy and which to hold or sell. Based on recent fund house calls, Mahindra & Mahindra (M&M), State Bank of India (SBI), Fortis Healthcare, and Apollo Tyres emerge as top buy-rated stocks, while LIC, Ola Electric, VRL […]
Read more
2025-02-06 (financialexpress.com)
Nomura maintains Buy, cuts target price on KEC International. Here's why... - Market News | The Financial Express
Nomura cuts KEC's target price to Rs 970 but maintains Buy on growth potential; explore more about it now!
Read more
2025-01-28 (businessupturn.com)
Nomura cuts target price for Macrotech Developers (Lodha) to Rs 1,450 |
Nomura maintained its buy rating on Macrotech Developers (Lodha) but cut its target price to Rs 1,450.
Read more
2025-01-24 (businessupturn.com)
Nomura cuts target price for Coforge after Q3FY25 results; check new price |
Nomura retains a ‘Buy’ rating on Coforge, with a marginal revision of the target price to ₹10,250 from ₹10,280. The brokerage has adjusted its FY25-27 EPS estimates by 0-6% to account for higher ESOP costs and tax rates in the near term. Despite these adjustments, Nomura continues to favor Coforge as its top pick in […]
Read more
2025-01-23 (marketbeat.com)
HDFC Bank (NYSE:HDB) Upgraded at Nomura |
Nomura upgraded HDFC Bank from a "neutral" rating to a "buy" rating in a report on Thursday.
Read more
2025-01-14 (businessupturn.com)
Nomura has a Rs 2,000 target price for HCLTech shares, retains Buy rating after Q3 results |
Nomura has maintained its 'Buy' rating on HCLTech with a target price of ₹2,000, despite what it termed a mixed Q3FY25 performance.
Read more
2024-12-19 (marketbeat.com)
Dr. Reddy's Laboratories (NYSE:RDY) Stock Rating Lowered by Nomura
Nomura cut shares of Dr. Reddy's Laboratories from a "buy" rating to a "neutral" rating in a research note on Thursday.
Read more